(Q48564199)

12 February 2018

5 references

20 June 2019

22 June 2019

19 September 2019

11 September 2020

9 April 2021

Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. (English)

1 reference

12 February 2018

biomedical investigative technique

main subject

1 reference

19 September 2019

1 reference

11 September 2020

1 reference

9 April 2021

1 reference

Victoria L Simpkin

1

1 reference

12 February 2018

Matthew J Renwick

series ordinal

2

1 reference

12 February 2018

Ruth Kelly

series ordinal

3

1 reference

12 February 2018

Elias Mossialos

series ordinal

4

1 reference

12 February 2018

publication date

1 November 2017

1 reference

12 February 2018

The Journal of Antibiotics

1 December 2017

5 references

20 June 2019

22 June 2019

19 September 2019

11 September 2020

9 April 2021

6 references

12 February 2018

20 June 2019

22 June 2019

19 September 2019

11 September 2020

9 April 2021

70

1 reference

12 February 2018

issue

12

1 reference

12 February 2018

page(s)

1087-1096

1 reference

12 February 2018

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

copyright license

5 references

20 June 2019

22 June 2019

19 September 2019

11 September 2020

https://scigraph.springernature.com/pub.10.1038/ja.2017.124

9 April 2021

exact match

0 references

cites work

Accelerating global innovation to address antibacterial resistance: introducing CARB-X.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Strategies for achieving global collective action on antimicrobial resistance

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Innovative Medicines Initiative and antibiotic resistance

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

The ABCs of the US Broad Spectrum Antimicrobials Program: Antibiotics, Biosecurity, and Congress

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Public funding of clinical-stage antibiotic development in the United States and European Union

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Repairing the broken market for antibiotic innovation

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

The future of antibiotics

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Antibiotics in the clinical pipeline in 2013.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

A Global Antimicrobial Conservation Fund for Low- and Middle-Income Countries

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5746591

Improving antibiotic markets for long-term sustainability

14 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29089600

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/JA.2017.124

1 reference

12 February 2018

Dimensions Publication ID

0 references

1 reference

12 February 2018

PubMed publication ID

29089600

1 reference

12 February 2018